COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,429 Articles (22,835 medRxiv, 8,594 bioRxiv)

Most recent first Previous |  Page 1342: Articles 13411-13420  | Next

High-risk alcohol consumption may increase the risk of SARS-CoV-2 seroconversion: a prospective seroepidemiologic cohort study among American college students
Kianersi, S., Ludema, C., Macy, J. T., Chen, C., Rosenberg, M.
10.1101/2021.08.03.21261444 — Posted: 2021-08-05
Quantifying the ongoing epidemic of disability after covid-19 in the UK population aged under 35 years; secondary analysis of the ONS Infection Survey
Spiers, N.
10.1101/2021.08.04.21261360 — Posted: 2021-08-05
Population normalisation in wastewater-based epidemiology for improved understanding of SARS-CoV-2 prevalence: A multi-site study
Sweetapple, C., Wade, M. J., Grimsley, J. M. S., Bunce, J. T., Melville-Shreeve, P., Chen, A.
10.1101/2021.08.03.21261365 — Posted: 2021-08-05
Temporal considerations in the 2021 COVID-19 lockdown of Ho Chi Minh City
Plan, E. L. C. V. M., Le, H. T., Le, M. D., Phan, H.
10.1101/2021.08.04.21261332 — Posted: 2021-08-05
Building knowledge of university campus population dynamics to enhance near-to-source sewage surveillance for SARS-CoV-2 detection
Sweetapple, C., Melville-Shreeve, P., Chen, A., Grimsley, J. M. S., Bunce, J. T., Gaze, W., Fielding, S., Wade, M. J.
10.1101/2021.08.03.21261377 — Posted: 2021-08-05
Symptom Persistence Despite Improvement in Cardiopulmonary Health - Insights from longitudinal CMR, CPET and lung function testing post-COVID-19
Cassar, M. P., Tunnicliffe, E. M., Petousi, N., Lewandowski, A. J., Xie, C., Mahmod, M., Abd Samat, A. H., Evans, R. A., Brightling, C. E., Ho, L.-P., Piechnik, S. K., Talbot, N. P., Holdsworth, D., Ferreira, V. M., Neubauer, S., Raman, B.
10.1101/2021.08.03.21260940 — Posted: 2021-08-05
Integrated miRNA/cytokine/chemokine profiling reveals immunopathological step changes associated with COVID-19 severity
WIlson, J. C., Kealy, D., James, S. R., Newling, K., Jagger, C., Filbey, K., Mann, E., Konkel, J., Menon, M., Knight, S. B., Simspon, A., CIRCO collaborative group, , Grainger, J. R., Hussell, T., Kaye, P. M., Signoret, N., Lagos, D.
10.1101/2021.08.04.21261471 — Posted: 2021-08-05
Negative impact of COVID-19 associated health system shutdown on patients diagnosed with colorectal cancer: a retrospective study from a large tertiary center in Ontario, Canada.
Forse, C. L., Petkiewicz, S., Teo, I., Purgina, B. M., Klaric, K.-A., Ramsay, T., Wasserman, J. K.
10.1101/2021.07.30.21261400 — Posted: 2021-08-05
SARS-CoV-2 antibody binding and neutralization in dried blood spot eluates and paired plasma
Itell, H. L., Weight, H., Fish, C. S., Logue, J. K., Franko, N., Wolf, C. R., McCulloch, D. J., Galloway, J., Matsen, F. A., Chu, H. Y., Overbaugh, J.
10.1101/2021.08.02.21261504 — Posted: 2021-08-04
An adaptive randomized controlled trial of non-invasive respiratory strategies in acute respiratory failure patients with COVID-19
Perkins, G. D., Ji, C., Connolly, B. A., Couper, K., Lall, R., Baillie, J. K., Bradley, J. M., Dark, P., Dave, C., De Soyza, A., Dennis, A. V., Devrell, A., Fairbairn, S., Ghani, H., Gorman, E. A., Green, C. A., Hart, N., Hee, S. W., Kimbley, Z., Madathil, S., McGowan, N., Messer, B., Naisbitt, J., Norman, C., Parekh, D., Parkin, E. M., Patel, J., Regan, S. E., Ross, C., Rostron, A. J., Saim, M., Simonds, A. K., Skilton, E., Stallard, N., Steiner, M., Vancheeswaran, R., Yeung, J., McAuley, D. F., Recovery- RS collaborators
10.1101/2021.08.02.21261379 — Posted: 2021-08-04 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).